St. Jude Medical, Inc. Second Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component St. Jude Medical, Inc. (NYSE:STJ) will unveil its latest earnings on Wednesday, July 20, 2011. St. Jude Medical Inc. develops, manufactures and distributes cardiovascular medical devices.

St. Jude Medical, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 84 cents per share, a rise of 6.3% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month. For the year, analysts are projecting profit of $3.31 per share, a rise of 10% from last year.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting net income of 80 cents per share against a mean estimate of profit of 78 cents per share.

Savvy Investing Tip: Our CHEAT SHEET investing framework recommends only stocks with two straight quarters of earnings growth. Learn More >>

Wall St. Revenue Expectations: On average, analysts predict $1.45 billion in revenue this quarter, a rise of 10.7% from the year ago quarter. Analysts are forecasting total revenue of $5.73 billion for the year, a rise of 11% from last year’s revenue of $5.16 billion.

Analyst Ratings: Analysts are bullish on this stock with 23 analysts rating it as a buy, two rating it as a sell and 14 rating it as a hold.

Key Stats:

The decrease in profit in the first quarter breaks a streak of three consecutive quarters of year-over-year profit increases. Net income fell 2.2% in the first quarter from the year earlier, while the figure rose 8.9% in the fourth quarter of the last fiscal year, 24.8% in the third quarter of the last fiscal year and 15.8% in the second quarter of the last fiscal year.

Revenue has risen the past four quarters. Revenue increased 9% to $1.38 billion in first quarter. The figure rose 12.2% in the fourth quarter of the last fiscal year from the year earlier, climbed 6.9% in the third quarter of the last fiscal year from the year-ago quarter and 10.8% in the second quarter of the last fiscal year.

Competitors to Watch: Medtronic, Inc. (NYSE:MDT), Boston Scientific Corp. (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Hansen Medical, Inc. (NASDAQ:HNSN), Greatbatch Inc. (NYSE:GB), Cardima, Inc. (CADMQ), AtriCure Inc. (NASDAQ:ATRC), Volcano Corporation (NASDAQ:VOLC), C.R. Bard, Inc. (NYSE:BCR), and Stereotaxis, Inc. (NASDAQ:STXS).

Stock Price Performance: During May 17, 2011 to July 14, 2011, the stock price had fallen $5.92 (-11.5%) from $51.47 to $45.55. The stock price saw one of its best stretches over the last year between July 29, 2010 and August 9, 2010 when shares rose for eight-straight days, rising 6% (+$2.16) over that span. It saw one of its worst periods between December 30, 2010 and January 7, 2011 when shares fell for seven-straight days, falling 5.4% (-$2.28) over that span. Shares are up $3.17 (+7.5%) year to date.

(Source: Xignite Financials)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!